Current Pharmaceutical Design

Author(s): A. K. Burroughs, E. Xirouchakis, A. Sigalas, P. Manousou, V. Calvaruso, M. Pleguezuelo, A. Corbani, S. Maimone and D. Patch

DOI: 10.2174/138161208783497705

DownloadDownload PDF Flyer Cite As
Models for Non-Alcoholic Fatty Liver Disease: A Link with Vascular Risk

Page: [378 - 384] Pages: 7

  • * (Excluding Mailing and Handling)

Abstract

Non alcoholic fatty liver disease (NAFLD) is often part of the metabolic syndrome which includes central obesity, dyslipidaemia, insulin resistance/type 2 diabetes mellitus and hypertension. In turn, NAFLD may be associated with an increased vascular risk. Several experimental models which express histological steatosis or steatohepatitis with fibrosis have been described. This review identifies those models of NAFLD with features of vascular risk.

Keywords: Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, vascular risk